Relaunch goals: Orbis aiming to achieve $18.5m sales target with new skin ageing care range

Orbis is one of the two flagship brands of Japanese cosmetics conglomerate Pola Orbis, which also owns brands POLA, Jurlique, and THREE. According to the firm’s latest financial results, Orbis accounts for 25% of the company’s total beauty sales.

Launched in 2018, the Orbis U series tackles skin ageing concerns. As of April 2022, the brand has moved over 13 million units of the range and won multiple awards.

This August, Orbis will be relaunching the three-piece range domestically through its physical retail network and online channels.

Following its domestic debut, the new series will be rolled out overseas to markets including China, Taiwan, Singapore, Malaysia, Thailand, and the US.

The new line is based on its latest mitophagy research, which illustrated that decreased mitophagy activity can adversely affect the production of ceramide production in skin and the skin’s ability to keep itself moisturised.

According to the firm, the skin’s main function is to protect the body from external dryness and irritation, and to do so, it hinges on its ability to create moisture and keep itself hydrated.

Orbis said this range focuses on building the “basic physical strength of the skin.”​

The new range of products now contain new ingredients, including St. John’s Wort extract. According to the firm, it is rich in tannins and flavonoids. Pola Orbis’ own research has also concluded that it can ‘turn on the moisturising switch’ of the skin and improve skin firmness.

It also retains Key Porin Booster, a blend of eelgrass extract, peach leaf extract and cornflower extract. It increases the circulation of moisture in and out of cells improving the skin’s plumpness, radiance, and maintains its youthful appearance. 

Additionally, the range also contains DF-Panthenol, the firm’s proprietary ingredient, which helps to reinforce the skin barrier and protect the skin from damage. The lack of moisture directly affects skin health, and therefore the overall quality of the skin.

In the last financial year, Orbis recorded a sales dip of 0.7% but saw operating profits rise 27.5%, despite challenges posed by COVID-19 triggered lockdowns in China and Hong Kong, as well as the sluggishness of the domestic offline market

This was attributed in part to the popularity of the Orbis U series, which accounted for 27% of the brand’s total sales.